Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS

v3.19.1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating expenses:    
Research and development $ 10,241 $ 9,439
General and administrative 1,119 986
Loss from operations (11,360) (10,425)
Interest income (91) (48)
Net Loss $ (11,269) $ (10,377)
Net loss per common share outstanding, basic and diluted $ (0.82) $ (1.03)
Weighted average number of common shares outstanding, basic and diluted 13,742,649 10,099,331